Strikingly, IACS-13909 alone was highly effective in reducing the tumor size by approximately 61%, likely owing to a sufficient combination of both SHP2 and off-target autophagy inhibition (Figure 6E and Supplemental Figure 6B). This evidence concerns the gene PTPN11 and neoplasm.